baber/WOPTO huggingface dataset:
Patent CZ-170197-A3 (CZ)
Title: Device for introducing intrauterine corpuscle
Inventor: MACANDREW JOHN ALEXANDER
IPC: A61F6/14
Filed: 1995-12-05
Abstract: PCT No. PCT/FI95/00666 Sec. 371 Date Jun. 2, 1997 Sec. 102(e) Date Jun. 2, 1997 PCT Filed Dec. 5, 1995 PCT Pub. No. WO96/18365 PCT Pub. Date Jun. 20, 1996An inserter for the positioning of an intrauterine device in the uterus, which inserter includes a plunger, a handle attached to the plunger, a string for the removal of the IUD, a locking device to lock the string in such a way that the IUD remains immobile in relation to the plunger, and a protective tube around the plunger. The protective tube is arranged in relation to the plunger in such a way that it can be pushed, at the forward end that goes into the uterus, past the plunger at distance (L) , which corresponds substantially to the length of the IUD assembled for insertion. The stop members ensure that the front edge of the protective tube is stopped in a configuration in which the hemispherical tips of the wings of the transverse member of a T-shaped IUD remain partly uncovered by the protective tube, but the wings nevertheless remain pressed against each other.
Patent CZ-199798-A3 (CZ)
Title: Cyclic sulfone derivative, process of its preparation and pharmaceutical composition containing thereof
Inventor: BAUMGARTH MANFRED
IPC: C07D277/62
Filed: 1996-12-16
Abstract: Cyclic sulphones of formula (I) are disclosed, in which: R<1> and R<2> each independently of one another stand for H, A, CF3, CH2F, CHF2, C2F5, Hal, OH, OA, NH2, NHA, NA2, NO2 or CN; X stands for CR<4>R<5>, C=Z, O, S, NH, NA or NR<3>; Y stands for CR<6>R<7>, C=Z, O, NH, NA, or NR<3>; Z stands for O, S, NH, NA, NOH, NOA, CH2, CHA or CA2; R<4>, R<5>, R<6> and R<7> each independently of one another stand for H, A, R<3>, Hal, OH, OA, SH, SA, NH2, NHA or NA2, or alternatively, R<5> and R<6> or R<7> and R<8> can together represent a bond, only one such bond being present in each molecule; R<4> and R<5> together can also stand for O-(CH2)2-O or O-(CH2)3-O; R<8> and R<9> each independently of one another stand for H or A; A stands for alkyl with 1-6 C atoms; Hal stands for F, Cl, Br or I; and R<3> stands for phenyl or benzyl which is unsubstituted or single-, double- or triple-substituted by A, OA, NH2, NHA, NA2, F, Cl, Br and/or CF3; and n is 0 or 1. Also disclosed are the physiologically tolerable salts of these compounds. These compounds and their salts have anti-arrhythmic properties and act as inhibitors of the cellular Na+/H+-antiporter.
Patent CZ-201531-A3 (CZ)
Inventor: ŽVÁTORA PAVEL
IPC: A61K47/38
Filed: 2015-01-21
Abstract: Předložené řešení se týká amorfní směsi vortioxetinu nebo jeho hydrobromidové soli s polymerem vyznačující se tím, že polymer je zvolený z derivátů polyakrylátů, (poly)methakrylátů, celulózy nebo z derivátů (poly)vinylu. Dalším řešením je způsob přípravy amorfní směsi, zahrnující rozpuštění vortioxetinu ve formě báze nebo ve formě hydrobromidové soli s vhodným polymerem vybraným z řady deriváty polymethakrylátu polyvinylpyrrolidon, hydroxypropylmethylcelulóza a hydromelóza acetát sukcinát ve vhodném organickém rozpouštědle vybraném z řady methanol, ethanol, izopropylalkohol, ethylacetát, aceton, dichlormethan, tetrahydrofuran nebo jejich směsi a následné odstranění rozpouštědla za vzniku amorfní směsi. Dalším způsobem přípravy je smíchání vortioxetinu ve formě báze nebo ve formě hydrobromidové soli s vhodným polymerem vybraným z řady deriváty polymetakrylátu polyvinylpyrrolidon, hydroxypropylmethylcelulóza a hypromelóza acetát sukcinát a následné zahřátí této směsi za vzniku taveniny a tvorby amorfní směsi.
Patent CZ-202026-A3 (CZ)
Inventor: ROH JAROSLAV
IPC: A61P39/00
Filed: 2020-01-16
Abstract: Kardioprotektivně účinné látky na bázi analog látky ICRF-193 obecného vzorce I, kde R1, R2 = H, 2-R3-2-aminoacetoxymethyl, přičemž R3 je vybrán ze skupiny sestávající z H, C1-C6 alkylu či rozvětveného alkylu nebo benzylu. Tyto sloučeniny lze vyrobit jednoduchými syntézami a vyznačují se nízkou toxicitou a vysokou účinností proti chronické kumulativní kardiotoxicitě způsobené terapií antracyklinovými protinádorovými léčivy. Řeší se i farmaceutický přípravek obsahující jako účinnou látku sloučeninu obecného vzorce I, jakož i použití této sloučeniny pro výrobu farmaceutického přípravku k prevenci chronické kumulativní kardiotoxicity způsobené terapií antracyklinovými protinádorovými léčivy.
Patent CZ-208598-A3 (CZ)
Title: Nisine in combination with glycerolmonolaurate exhibiting activity against heliobacter strain
Inventor: BLACKBURN PETER
IPC: A61P31/04
Filed: 1997-01-02
Abstract: Disclosed are compositions of nisin and GML as active ingredients for the killing of <u>Helicobacter</u>, as well as methods for eradicating <u>Helicobacter</u> colonization and treatment of <u>Helicobacter</u> infection which employ the GML/nisin compositions.
Patent CZ-226095-A3 (CZ)
Title: The use of anticonvulsive agents for preparing medicaments intended for treating neuronal degeneration caused by aids
Inventor: BOUSSEAU ANNE
IPC: C07D253/06
Filed: 1994-02-25
Abstract: The invention relates to the application of riluzole or the pharmaceutically acceptable salts of this compound in the treatment of neuro-AIDS.
Patent CZ-264498-A3 (CZ)
Title: Hybrid proteins forming heterodimers, process of their preparation and administration
Inventor: CAMBELL ROBERT K
IPC: C07K14/59
Filed: 1997-02-20
Abstract: A hybrid protein includes two coexpressed amino acid sequences forming a dimer. Each sequence contains the binding portion of a receptor, such as TBP1 or TBP2, or a ligand, such as IL-6, IFN-β and TPO, linked to a subunit of a natural heterodimeric scaffold. Each coexpressed sequence contains a corresponding subunit so as to form a heterodimer upon expression. Corresponding DNA molecules, expression vectors and host cells are also disclosed as are pharmaceutical compositions and a method of producing such proteins.
Patent CZ-297097-A3 (CZ)
Inventor: FLICEK FRANTISEK
IPC: F04B9/00
Filed: 1997-09-22
Abstract: Pístový stroj obsahuje alespoň jeden válcový
blok /1/, obsahující alespoň jeden stacionární
válec /5/, v němž je vratně uložen píst
/45/, pevně spojený s pístnlcí /44/. Ve válcovém
bloku /1 / je otočně uložen přímý hřídel
/2/, na němž je pevně uložen věnec /3/, který
je pomocí planetového kola /42/ spřažen s
pístnicí /44/ pístu /45/. Planetové kolo /42/
je přitom ve své ose otáčení uloženo na výkyvném
rameně /4/, které je otočně uloženo na
přímém hřídeli /2/. Planetové kolo /42/ je zárověň
mimo svoji osu otáčení otočně uloženo
na pístnicí /44/, která je s výhodou uložena
ve vedení, rovnoběžném s osou válce /5/.
Patent CZ-355297-A3 (CZ)
Title: Control of working and transport positions of cutting wheel of machine for band treatment and sowing soil and cover thereof
Inventor: BURES KAREL
IPC: A01B73/00
Filed: 1997-11-11
Abstract: Universal machine for land strip tilling and sowing permits by its functional assemblies not only to vary the depth and width of the tilled land strips and the width of left-out strips between them, but also the pressure of cultivator wheels on the tilled land surface. On an auxiliary frame (13) of the machine a lifter (15) and a balancer (16) are assembled. The lifter (15) is connected with an actuating lever (18), fastened on a swing arm (8). The locking fixture (36) locks the swing arm (8) in idle position to secure a safe handling of cultivator wheels (9) as well as the transport of the machine. The cultivator wheels (9) consist of at least one cutter head (58, 59, 60) with at least one cutter disk (71), to which tilling cutters (76, 77, 78) are fastened. The guard (10) of cultivator wheels (9) enables copying of the land surface profile during the motion of the machine and helps to shovel the thrown-out earth back into the cut-out groove.
Patent CZ-9904031-A3 (CZ)
Title: Tough-coated hard powders and sintered articles thereof
Inventor: TOTH RICHARD EDMUND
IPC: B22F1/18
Filed: 1998-05-13
Abstract: The present invention relates to a sintered material comprising a plurality of core particles, consisting of diamond or cubic boron nitride or one or more first metal compounds, wherein the or each first metal compound consists of a metal compound selected from the group consisting of: niobium carbide, tantalum nitride, TiN, TiCN, TiB 2 , TiC, ZrC, ZrN, VC, VN, Al 2 O 3 , Si 3 N 4  and AlN; an intermediate layer on each of the core particles, the intermediate layer consisting of a second metal compound, wherein the second metal compound consists of WC or W 2 C, thereby forming coated particles; and a binder overlaying the intermediate layer on the coated particles and constituting a layer including iron, cobalt, nickel, their mixtures, their alloys or their intermetallic compounds.
Patent SK-111796-A3 (SK)
Title: Manufacturing process of carbamate of cellulose
Inventor: STRUSZCZYK HENRYK
IPC: C08B15/06
Filed: 1996-08-30
Abstract: Cellulose carbamate is obtd. from opt. degraded cellulose by subjecting 1 pt. wt. cellulose (esp. as flakes) to alkaline reaction with 0.1-3 pts. urea (or salt). The reaction is effected in presence of a synergistic activating system comprising gaseous anhydrides of (in)organic acids and 0.001-10 pts. wt. (per 100 pts. wt. cellulose) of salts of (in)organic acids. The reaction occurs at 130-170 deg C for 10-600 mins., with the prod. opt. being purified.  Pref. the anhydrides in the activating system are CO2, SO2, CO and/or acetic anhydride, while the salts are Na-acetate, -formate, -carbonate or -sulphate, urea-formate or -acetate and/or Co(II)-formate or -acetate. The components of the activating system can be introduced separately, together or with the urea (or salt), such introduction into the cellulose being by mixing or soaking for 1-600 mins. at 20-60 deg C. Alternatively, the salts of the actuating system can be introduced into the cellulose in the course of a neutralisation reaction, again by mixing or soaking for 1-600 mins. at 20-60 deg C.
Patent SK-171498-A3 (SK)
Title: Process for the preparation of 4-aminodiphenylamine
Inventor: BESKA EMANUEL
IPC: C07C209/02
Filed: 1998-12-11
Abstract: Disclosed is a preparation method for 4-aminodiphenylamine through the intermediate preparation of 4-nitrodiphenylamine and/ or 4-nitrosodiphenylamine, and/ or salts thereof by the reaction of aniline with nitrobenzene in a liquid medium under the temperature 50 to 130  C, under the normal or reduced pressure, in the inert atmosphere or in the presence of gaseous oxygen, followed by hydrogenation of the intermediate 4-aminodiphenylamine and/ or nitrosodiphenylamine and by-products, by isolation of 4-aminodiphenylamine and by-products and by re-circulation of non-converted raw materials. The reaction of aniline with nitrobenzene with the selectivity at least 50 % to 4-nitrodiphenylamine and nitrosodiphenylamine is performed in the reaction system made by the solution of the real zwitteriones salts with hydroxides of general formula HO-/(R1R2R3)N+-CHR4-(CH2)x-Y-/Z+, wherein the meaning of the substituents is in the description. The 4-nitrosophenylamine and/ or 4-nitrodiphenylamine, and/ or salts thereof, are produced, which after the hydrogenation provide 4-ADFA and after the reaction at least a half of the reaction system is re-used for the next reaction and/ or is recycled.
Patent SK-176597-A3 (SK)
Title: Improved process for synthesizing carbapenem intermediates
Inventor: YANG CHUNHUA
IPC: C07F7/18
Filed: 1996-06-24
Abstract: A process of synthesizing a compound of formula (1) or (2) is disclosed wherein R represents H or methyl and P represents triethylsilyl or trimethylsilyl. A compound of formula (3) or (4) is reacted with P-C1 wherein P is as defined above, in the presence of base and a substantially non-reactive solvent to produce (1) or (2).
Patent SK-545290-A3 (SK)
Title: Method of preparation of 2'3'-dideoxy-2'-fluoronucleosides and 2'3'-dideoxy-2'3'-didehydro-2'-fluoronucleosides
Inventor: STERZYCKI ROMAN Z
IPC: A61K31/708
Filed: 1988-11-11
Abstract: There are disclosed novel 2 min ,3 min -dideoxy-2 min -fluoronucleosides and 2 min -3 min -dideoxy-2 min ,3 min -didehydro-2 min -fluoronucleosides and processes for their preparation. The compounds so produced exhibit therapeutically useful antiviral and, more particularly, anti-HIV effects.
Patent BE-1007872-A3 (BE)
Title: Optische aftastinrichting, alsmede een opteken- en/of uitleesinrichting voorzien van een dergelijke aftastinrichting.
Inventor: KAHLMAN JOSEPHUS A H M
IPC: G11B7/09
Filed: 1993-12-15
Granted: 1995-11-07
Abstract: Een aftastinrichting is voorzien van een optisch aftaststelsel (1,5,6,7) voor het met een eerste (3) en tweede stralingsbundel (2) herhaald aftasten van een registratievlak op een bandvormige registratiedrager (9). De eerste (3) en tweede aftastbundel (2) veroorzaken een eerste (11) en tweede aftastvlek (12) veroorzaken op het registratievlak van de registriedrager (9). De aftastvlekken (11,12) voeren synchrone bewegingen uit een eerste (16) en tweede aftastbaan (18) met voorafbepaalde verschillende aftastrichtingen, zodat de afstand, gezien in een richting y dwars op de aftastbanen (16 en 19) tussen de eerste (11) en de tweede aftastvlek (12) tijdens de aftasting verandert. De aftastinrichting kan worden toegepast in een optische opteken- en/of uitleesinrichting. De opteken- en/of uitleesinrichtingen is verder nog voorzien van een transportrol (14) voor het in de richting (y) dwars op de sporen verplaatsen van de bandvormige registratiedrager (9). Met behulp van detectiestelsel (70) wordt de van de tweede aftastvlek (12) afkomstige straling omgezet in een overeenkomstig detectiesignaal (S1). Een meetschakeling (72) leidt een positiemeetsignaal (Sp)...
Patent BE-1008455-A3 (BE)
Inventor: DIRVEN PAUL
IPC: H01M8/1004
Filed: 1994-06-07
Granted: 1996-05-07
Abstract: Gas diffusion electrode with catalyst for an electrochemical cell with solid electrolyte, in particular for a fuel cell with solid electrolyte, which electrode contains a hydrophobic, porous back support (12), a non-catalytic intermediate layer (13) which contains electron conductive material and an active catalytic layer (14) which contains bound catalyst particles, characterized in that the intermediate layer (13) contains a mixture of electron conductive material and a proton conductive ionomer, and in that the active layer (14) forms the outside layer and the catalyst particles are bound by a proton conductive ionomer <IMAGE>
Patent WO-0187343-A3 (WO)
Title: Polytherapie faisant appel a un inhibiteur selectif de cox-2 et a un inhibiteur de la thromboxane ainsi que des compositions contenant ceux-ci
Inventor: SCOLNICK EDWARD
IPC: A61P21/00
Filed: 2001-05-14
Abstract: L'invention concerne un procédé de traitement ou de prophylaxie de conditions pathologiques à médiation de COX-2 chez des patients présentant le risque de développer des complications thromboemboliques, qui comprend l'administration à ces patients d'une dose efficace du point de vue thérapeutique ou prophylactique d'un inhibiteur sélectif de COX-2 et d'une quantité protectrice du point de vue cardio-vasculaire d'un inhibiteur de la thromboxane. L'invention concerne également des compositions contenant ces inhibiteurs.
Patent WO-02092024-A3 (WO)
Title: Composes et methodes d'inhibition d'odeurs axillaires
Inventor: NATSCH ANDREAS
IPC: C07C323/32
Filed: 2002-05-14
Abstract: L'invention concerne des enzymes servant d'intermédiaire dans la libération de composés caractéristiques des mauvaises odeurs humaines, en particulier des odeurs axillaires, ainsi que des composés inhibant lesdites enzymes de formule générale (I).
Patent WO-0175000-A3 (WO)
Title: Nouveau polypeptide, facteur humain 15 lié á la rétrotransposition, et polynucléotide codant pour ce polypeptide
Inventor: MAO YUMIN
IPC: C07K14/47
Filed: 2001-02-26
Abstract: L'invention concerne un nouveau polypeptide, un facteur humain 15 lié à la retrotransposition, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des dystrophies musculaires, des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour le facteur humain 15 lié à la rétrotransposition.
Patent WO-03072012-A3 (WO)
Title: Composition d'adn pour administration orale destinee a combattre l'infection chronique par le virus de l'hepatite b
Inventor: NG MUNHON
IPC: A61K39/29
Filed: 2003-02-28
Abstract: La présente invention concerne une composition d'ADN pour administration orale destinée à réparer l'immunité affectée, associée à l'infection chronique par le virus de l'hépatite B (HBV) et supprimer l'expression des transgènes pendant une longue période. Elle comprend une souche atténuée de cellules bactérienne qui de préférence sont dirigées sur les cellules phagocytes de la muqueuse intestinale et qui servent de véhicule à un vecteur de plasmides transportant un ou plusieurs gènes ou d'ADN supplémentaire codant pour au moins une partie de la protéine ou du peptide du virus de l'hépatite B. Administrée par voie orale, la composition d'ADN provoque une infection passagère à auto-limitation du tractus intestinal par l'autolyse des cellules bactérienne et la libération du plasmide après avoir pénétré dans les cellules hôtes infectées. Un promoteur contenu dans le plasmide permet l'expression du ou des gènes du HBV dans un environnement eucariote, dont les produits viraux aident à déclencher une immunité à médiation par cellules pour éliminer l'infection et inverser un état caractéristique de tolérance immunitaire de l'infection chronique par HBV.
Patent CZ-59394-A3 (CZ)
Title: Condensed tricyclic heterocycles containing nitrogen as antagonists of p substance receptor, process of their preparation, intermediates, pharmaceutical preparations in which they are comprised and use
Inventor: LOWE JOHN A III
IPC: A61K31/435
Filed: 1992-08-20
Abstract: PCT No. PCT/US92/06819 Sec. 371 Date Sep. 15, 1994 Sec. 102(e) Date Sep. 15, 1994 PCT Filed Aug. 20, 1992 PCT Pub. No. WO93/06099 PCT Pub. Date Apr. 1, 1993.The present invention relates to novel fused tricycylic nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula    <IMAGE>  I   wherein R1, R2 and R3 are as defined below. These novel compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
Patent CZ-2003345-A3 (CZ)
Title: Securing element for secondary securing of glass within a light housing, particularly in car headlight
Inventor: STENCL ANTONIN ING
IPC: F21V17/10
Filed: 2003-02-05
Abstract: In the present invention, there is disclosed a securing element for secondary securing of a glass (3) within a light housing (1), particularly in a car headlight comprising a housing (1) with a continuous peripheral groove (11) performed on the edge thereof. Said continuous peripheral groove (11) interior is filled with a sealing compound (2) in which foot portion (31) of a glass (3) is embedded. The invention is characterized in that the proposed securing element is formed by a central supporting portion (41) put onto outer side of the continuous peripheral groove (11) outer wall (112), and further by two substantially parallel arms (42), whereby al least one arm (42) passes over said continuous peripheral groove (11) outer wall (112) into the glass (3) foot portion (31).
Patent CZ-2003700-A3 (CZ)
Title: Process for preparing adamantane compounds
Inventor: KOJIMA AKIO
IPC: C07B61/00
Filed: 2002-01-31
Abstract: The invention relates to a method of selectively producing adamantanes in a production apparatus made of an inexpensive material, not having any negative influence on the natural environment. The method for producing adamantanes includes isomerizing a tricyclic saturated hydrocarbon having at least 10 carbon atoms in the presence of a metal-carrying solid acid catalyst, wherein an unsaturated bond-having compound is made to coexist along with the catalyst during the isomerization.
Patent CZ-2004738-A3 (CZ)
Inventor: VEVERKA MIROSLAV
IPC: C07D207/34
Filed: 2004-06-17
Abstract: Resení se týká zpusobu stanovení enantiomerní cistoty 2-(4-fluorfenyl)-.beta.,delta-dihydroxy-5(1-methylethyl)-3-fenyl-4-[(fenylamino)-(karbonyl]-1H-pyrrol-1-heptanové kyseliny a jejích solí vzorce Imetodou chirální chromatografie. Stanovení je mozno pouzít pri kontrole substance léciva nebo v kapalných a pevných lékových formách.
Patent CZ-2007410-A3 (CZ)
Inventor: MIKODA JIRI
IPC: F23C10/00
Filed: 2007-06-14
Abstract: Fluidní topenište teplárenského kotle na uhlí ci uhlí a biomasu s prívodem vápence je shora a z boku tvoreno membránovými stenami (1), které jsou zcela nebo cástecne opatreny oteruvzdornou vrstvou keramického žáruvzdorného materiálu a zespoda je vymezeno trubkovým propadovým roštem, fluidní topenište obsahuje oxidacní fluidní spalovací vrstvu hrubozrnného kremicitého písku o granulometrii z rozmezí 0,4 až 3 mm, ve které je pod sesypem (4.1) nebosesypy (4.1) a (4.2) ve výšce alespon 80 mm nad trubkovým propadovým roštem instalován rídící teplomer (T) propojený pres rídící pocítac (R) s regulátorem otácek (N) dávkovace (5.1) paliva nebo dávkovacu (5.1) a (5.2) paliva a s regulacní klapkou (33) potrubí fluidacního média ventilátoru (7), dávkovac (5.1) paliva nebo dávkovace (5.1) a (5.2) paliva jsou spojeny se sesypem (4.1) nebo se sesypy (4.1) a (4.2) v celní membránové stene (1) fluidního topenište, sesyp (4.1) nebo sesypy (4.1) a (4.2)jsou napojeny na potrubní trasu prívodu sekundárního spalovacího média, trubkový propadový rošt je spojen s ventilátorem (7) fluidacního média, kterýje napojen na sací potrubí spalovacího vzduchu a na potrubí recyklážích spalin napojené na trasu spalin za kourovým ventilátorem (25).
Patent CZ-2007844-A3 (CZ)
Inventor: NEUMANN JACEK
IPC: G01R27/02
Filed: 2007-11-30
Abstract: Rešení se týká zpusobu stanovení prvku náhradníhoschématu reálného dielektrika pri merení izolacního odporu, pri kterém se merí proud procházející dielektrikem a jeho závislost na case, pricemž pro dielektrikum platí, že casová konstanta obvodu RC1<< R2C2, kde R je vnitrní odpor zdroje, R1 je svodový odpor, C1 je geometrická kapacita daného dielektrika, R2 odporová složka polarizacních deju v dielektriku a C2 je kapacitní složka techto polarizacních deju. Hodnoty R1, R2, T.sub.s.n. se podle zmerených údaju stanoví ze vztahu  R1 = U/A kde  U je mericí napetí  A je koeficient stanovený iteracemi pro nejvetší absolutní hodnotu korelacního koeficientu r R2 = U/EXP/(a) kde  U je mericí napetí  a je úsek na ose y pro x = 0, stanovený iteracemi  Ts = 1/b kde b je smernice prímky, stanovené iteracemi a C2 = T.sub.s.n./R2, kde T.sub.s.n. je casová konstanta stanovená iteracemi.
Patent CZ-2009757-A3 (CZ)
Inventor: SVOBODA LIBOR
IPC: B01D46/10
Filed: 2009-11-13
Abstract: Komínový filtr je tvoren tkaninou (2) z nehorlavých a tepelne odolných filtracních vláken, která se vkládá do telesa (1) komínu, ke kterému je uchycena upevnovacím držákem (3). Do steny telesa (1) muže být umísten oklepávac (4) pro oklepávání necistot z plochy tkaniny (2). Pro výrobu tkaniny (2) se zpravidla používají skelná, keramická nebo minerální vlákna. Pro zvetšení filtracní plochy muže být tkanina (2) provedena do tvaru obrazcu.